News

Find News

Filter articles

Applied Filters

Showing 721 to 730 of 919 results

Celgene company suffers Abraxane patent rejection in India

India03-06-2015

The Indian Patent Office has reportedly rejected an application covering US company Abraxis BioScience’s cancer drug Abraxane.

Novartis sues Apotex at New Jersey court to protect Zometa

US02-06-2015

Novartis has sued Apotex at the US District Court for the District of New Jersey to protect its drug Zometa from generic competition.

Actavis plan to switch Namenda drug was unlawful, says US court

US01-06-2015Legal developments

A US appeals court has ruled that Actavis’s attempt to force Alzheimer’s patients to switch from one medication to another before generic companies entered the market was anti-competitive.

Teva to pay $1.2bn in FTC ‘pay-for-delay’ case

US29-05-2015

Israel-based pharmaceutical company Teva will have to fork out $1.2 billion after a long-running dispute with the US Federal Trade Commission over a controversial ‘pay-for-delay’ case was settled.

Par cleared but Watson liable over Novartis patents

US26-05-2015

A US appeals court has issued a mixed judgment in a patent dispute that saw Novartis file infringement claims against both Watson Pharmaceuticals and Par Pharmaceutical.

Indian Supreme Court stops Glenmark from making generic Januvia

India18-05-2015

The Supreme Court of India has ordered Glenmark Pharmaceuticals to stop making generic versions of Merck Sharp & Dohme’s diabetes drugs Januvia and Janumet.

AIDS group warns of TPP’s impact on access to generic medicine

US13-05-2015

The Foundation for AIDS Research has warned that the Trans-Pacific Partnership’s changes to IP policy could restrict access to affordable generic medicines in low and middle income countries.

Californian Supreme Court allows Cipro pay-for-delay challenge

US11-05-2015

The Supreme Court of California has ruled that so-called “pay-for-delay” patent settlements can be challenged under state antitrust law in a case centering on Bayer’s antibiotic drug Cipro.

US court hands down Absorica claim construction

US28-04-2015

A US court has ruled on how five claims in two patents related to acne drug Absorica should be construed, in a patent infringement case between Canada-based Cipher Pharmaceuticals and Actavis.

Shire sues Amneal over proposed generic Lialda

US24-04-2015

Drug maker Shire, alongside two other companies, has sued Amneal Pharmaceuticals for allegedly infringing a patent related to Lialda, a drug for treating ulcerative colitis.

Showing 721 to 730 of 919 results

LSIPR